We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Temporal Artery Biopsy in Giant Cell Arteritis—Reply

Lindsey B. De Lott, MD, MS1,2; James F. Burke, MD, MS1; Jonathan D. Trobe, MD1,2
[+] Author Affiliations
1Department of Neurology, University of Michigan, Ann Arbor
2Department of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center, Ann Arbor
JAMA Ophthalmol. 2015;133(10):1220-1221. doi:10.1001/jamaophthalmol.2015.2554.
Text Size: A A A
Published online


In Reply We appreciate the thoughtful comments of Grzybowski and Stacy regarding the use of laboratory markers in deciding whether to perform TAB in patients with possible GCA. We agree that TAB is important not only for establishing the diagnosis of GCA but also for justifying the use of long-term corticosteroid therapy from which nearly all patients will experience adverse effects. Additionally, TAB may confirm the diagnosis in patients with normal laboratory markers but a suspicious clinical picture.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 1, 2015
Andrzej Grzybowski, MD, PhD; Rebecca C. Stacy, MD, PhD
1Department of Ophthalmology, Jozef Strus Poznań City Hospital, Poznań, Poland2Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland
3Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston4Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston5Novartis Institutes for BioMedical Research, Cambridge, Massachusetts
JAMA Ophthalmol. 2015;133(10):1220. doi:10.1001/jamaophthalmol.2015.2552.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...